Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass

Annals of Thoracic Surgery

Volumn 63, Issue 5, 1997, Pages 1361-1367

  Lundblad, Runar ^a   Moen, Oddvar ^a   Fosse, Erik ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; GLYCOPROTEIN; HEPARIN; LACTOFERRIN; MYELOPEROXIDASE;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL;

CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYTIC AGENTS; HEART DISEASES; HEPARIN; HUMANS; LACTOFERRIN; MALE; NEUTROPHIL ACTIVATION; PEROXIDASE;

EID: 0031149536     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)00088-X     Document Type: Article

References (32)

1. 1. Fosse E, Moen O, Johnson E, et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1994;58:472-7.
2. 2. Øvrum E, Mollnes TE, Fosse E, et al. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg 1995;110: 1623-32.
3. 3. Øvrum E, Fosse E, Mollnes TE, et al. Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation. Eur J Cardiothorac Surg 1996;10:54-60.
4. 4. Weitzberg E, Lundberg JM, Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 1991;33:222-7.
5. 5. Steinberg BM, Grossi EA, Schwartz DS, et al. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 1995;60:525-9.
6. 6. Moen O, Fosse E, Brockmeier V, et al. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems. Ann Thorac Surg 1995;60:1317-23.
7. 7. Van Beaumont W. Evaluation of hemoconcentration from hematocrit measurements. J Appl Physiol 1972;32:712-3.
8. 8. Olofsson T, Olsson I, Venge P, Elgefors B. Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol 1977;18:72-80.
9. 9. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990;300:230-5.
10. 10. Knothe CH, Boldt J, Zickmann B, Ballesteros M, Dapper F, Hempelmann G. Endothelin plasma levels in old and young patients during open hearth surgery: correlations to cardiopulmonary and endocrinology parameters. J Cardiovasc Pharamacol 1992;20:664-70.
11. 11. Shirakami G, Magaribuchi T, Shingu K, et al. Effects of anesthesia and surgery on plasma endothelin levels. Anesth Analg 1995;80:449-53.
12. 12. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
13. 13. Lopez-Farre A, Riesco A, Espinosa G, et al. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 1993;88:1166-71.
14. 14. Sessa W, Kaw S, Hecker M, Vane JR. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Comm 1991;174:613-8.
15. 15. Pittet JF, Morel DR, Hemsén A, et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 1991;213:261-4.
16. 16. Firth JD, Ratcliffe PJ, Raine AEG, Ledingham JGG. Endothelin: an important factor in acute renal failure? Lancet 1988;2: 1179-82.
17. 17. Morise Z, Ueda M, Aiura K, Endo M, Kitajima M. Pathophysiologic role of endothelin-1 in renal function in rats with endotoxin shock. Surgery 1994;115:199-204.
18. 18. Hiramatsu T, Forbess JM, Miura T, Roth SJ, Cioffi MA, Mayer JEJ. Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts. Circulation 1994;90(Suppl 1):422.
19. 19. McNamara DB, Light JT, Minkes RK, et al. Comparative effects of endothelin (ET-1) and U46619 on human saphenous vein and gastroepiploic artery, sources of human autologous grafts. Mol Cell Biochem 1992;117:81-5.
20. 20. Auguet M, Delaflotte S, Chabrier PE, Braquet P. Characterization of endothelin receptors mediating contraction and relaxation in rabbit saphenous artery and vein. Can J Physiol Pharmacol 1993;71:818-23.
21. 21. Tschudi MR, Luscher TF. Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor. Biochem Biophys Res Commun 1994;204:685-90.
22. 22. White DG, Garratt H, Mundin JW, Sumner MJ, Vallance PJ, Watts IS. Human saphenous vein contains both endothelin ETA and ETB contractile receptors. Eur J Pharmacol 1994; 257:307-10.
23. 23. Karaki H, Sudjarwo SA, Shimamoto N, Wakimasu M, Fujino M. Effects of a potent, non-selective endothelin receptor antagonist, [Thr18, gamma-MeLeu19]-endothelin-1, on the isolated blood vessels. Biochem Biophys Res Commun 1995; 212:421-7.
24. 24. He GW, Yang CQ. Comparison among arterial grafts and coronary artery. An attempt at functional classification. J Thorac Cardiovasc Surg 1995;109:707-15.
25. 25. He GW, Acuff TE, Ryan WH, Yang CQ, Mack MJ. Functional comparison between the human inferior epigastric artery and internal mammary artery. Similarities and differences. J Thorac Cardiovasc Surg 1995;109:13-20.
26. 26. He GW, Yang CQ, Starr A. Overview of the nature of vasoconstriction in arterial grafts for coronary operations. Ann Thorac Surg 1995;59:676-83.
27. 27. Seo B, Oemar BS, Siebenmann R, von SL, Luscher TF. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994;89:1203-8.
28. 28. Unger P, Berkenboom G, De SJ, Depierreux M, Fontaine J. Influence of the endothelium on the responses to endogenous agonists in human internal mammary and gastroepiploic arteries. Arch Int Pharmacodyn Ther 1992;320:56-67.
29. 29. He GW, Acuff TE, Yang CQ, Ryan WH, Mack MJ. Middle and proximal sections of the human internal mammary artery are not "passive conduits." J Thorac Cardiovasc Surg 1994;108:741-6.
30. 30. He GW, Ryan WH, Acuff TE, Yang CQ, Mack MJ. Greater contractility of internal mammary artery bifurcation: possible cause of low patency rates. Ann Thorac Surg 1994;58: 529-32.
31. 31. He GW, Yang CQ, Mack MJ, Acuff TE, Ryan WH, Starr A. Interaction between endothelin and vasodilators in the human internal mammary artery. Br J Clin Pharmacol 1994;38: 505-12.
32. 32. Liu JJ, Casley D, Wojta J, et al. Effects of calcium- and ETA-receptor antagonists on endothelin-induced vasoconstriction and levels of endothelin in the human internal mammary artery. Clin Exp Pharmacol Physiol 1994;21:49-57.